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Abstract 
 Introduction: hypertension may be affected by environment. The 
variation of altitudes has been reported to play a role in hypertension. In 
Jordan, we have an environment rich in diversity as having areas in the sea 
level and others in the lowest depth in the world (the Dead Sea).  
Objectives: to examine the impact of altitudes on the level of angioten II 
among study participants. 
Methods and subjects: across sectional design was conducted. Two areas 
were included: the Dead Sea and the Sea level area, Jordan. The study sample 
included a total of 1000 participants of them 500 participants were included 
from each area. All participants were males, matched for age grouping, and 
they were apparently healthy. A working paper was made for each participant 
which included study variables such as blood pressure, weight, height, waist 
circumference, heart rate per minute, the level of angiotensin II, and packed 
cell volume (PCV). We analyzed data using SPSS version 20. All data were 
included and represented as mean and standard deviation. The relations 
between variables were computed using independent T test. Significance was 
considered at alpha <0.05. 
Study findings: there were no statistical differences between study groups for 
all variables except systolic blood pressure which its mean was 122.42±10.53 
mmHg in the area of Dead Sea and this was significantly higher than that of 
the Sea level (118.07±11.64) (p=0.001). The mean of blood pressure in the 
Dead Sea was 91.64 ±   8.90 mmHg, and this was significantly higher than 
European Scientific Journal December 2016 edition vol.12, No.36 ISSN: 1857 – 7881 (Print) e - ISSN 1857- 7431 
142 
that of the Sea level (89.84 ± 8.72) (p=0.001). The level of angiotensin II was 
8.48±4.65pg/ml in the Dead Sea area, and this was less than that of the Sea 
level (11.21± 6.05pg/ml). The difference in means for angiotensin II was not 
statistically significant. 
Conclusion: the altitude differences in the study area affected, but not 
significantly, the level of angiotensin II and significantly the level of systolic 
blood pressure. 
Keywords:  Hypertension, altitude, angiotensin II, the Dead Se. 
 
Introduction 
 Blood pressure means the force exerted by the blood against any unit 
area of the vessel wall (Urone, 1986); this force pushes blood to the different 
parts of the body to supply nutrients to the tissues and remove waste products 
away, i.e. to maintain homeostasis in all tissue fluids of the body for optimal 
survival and function of the cells (Guyton and Hall, 2006). Blood pressure 
develops normally in the left ventricle during the systolic part of the cardiac 
cycle (Ganong, 1997). Blood flow through the blood vessel depends mainly 
on the pressure gradient, wh\r4.ffv.vich is the force that pushes the blood 
through the vessel (P= F X R), whereas, P is pressure gradient, F is blood flow; 
R is the resistance (Guyton and Hall, 2006). Arterial blood pressure is 
regulated within a narrow range by baroreceptors to provide adequate 
perfusion of the tissues without causing damage to vascular system, 
particularly the arterial intima (Harvey and Champe, 2006). Mean arterial BP 
is a function of cardiac output (CO) and total peripheral vascular resistance 
(TPR) (Berne and Levy, 2001) and, in mathematical terms, at constant CO, 
BP =CO X TPR. CO, in turn, is directly related to ECF volume and the volume 
of the venous return to the heart. Indeed, Borst and Borst-de Geus, 1963; 
Guyton and Coleman (1969),  and Guyton, Jones and Coleman 
(1973)observed that acute plasma volume expansion elevates the BP by 
increasing CO. Most patients with chronically elevated BP have a relatively 
normal CO and significantly elevated TPR(Cowley, 1992; Williams and 
Wilkins, 2002). According to Guyton, the tissue over-perfusion is an abnormal 
condition, and TPR, therefore, increases until tissue perfusion returns to 
normal. One explanation is that this autoregulation is controlled by the 
metabolic demands of the tissues (Borst and Borst-de Geus, 1963; Guyton, 
Jones and Coleman, 1973; Williams and Wilkins, 2002).  
         Angiotensin I is converted to angiotensin II through removal of two 
terminal residues by the enzyme Angiotensin-converting enzyme (ACE), 
which is found predominantly in the capillaries of the lungs (Basso and 
Terragno, 2001). ACE is actually found all over the body, but it has its highest 
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density in the lung. Angiotensin II acts as an endocrine, autocrine/ paracrine, 
and intracrine hormone (Devlin, 2006). 
 ACE is a target for inactivation by ACE inhibitor drugs, which 
decrease the rate of angiotensin II production. Angiotensin II increases blood 
pressure by stimulating the Gq protein in vascular smooth muscle cells (which 
in turn activates contraction by an IP3-dependent mechanism). ACE inhibitor 
drugs are major drugs against hypertension. 
 Angiotensin II is degraded to angiotensin III by angiotensinases that 
are located in red blood cells and the vascular beds of most tissues. It has a 
half-life in circulation of around 30 seconds, while in tissues; it may be as long 
as 15-30 minutes (Skurk, Lee, Hauner, 2001).   
 
Study objectives 
 The main objective of the current study is to examine the impact of 
altitudes on the level of angiotensin II among study participants. 
 
Methods and subjects 
Study design 
 Cross sectional design was conducted. 
 
Study setting 
 The present study was conducted in two areas: the Dead Sea and the 
Sea  level area, Jordan. 
 
Study sample 
 The study sample included a total of 1000 participants of them 500 
participants were included from each area. All participants were males, 
matched for age grouping, and they were apparently healthy. 
 
Data collection  
 A working paper was made for each participant which included study 
variables such as blood pressure, weight, height, waist circumference, heart 
rate per minute, the level of angiotensin II, and  packed cell volume (PCV). 
 
Study procedure 
Blood pressure measurements 
 Blood pressure was taken for 500 subjects in each target area; it was 
taken from the right arm of the subject, in a sitting position and after resting 
for 5 minutes. Blood pressure was taken by sphygmomanometer with a 
stethoscope. 
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Measurement of height 
 Height was measured for our subjects by using 2 metric scaled rulers 
fixed to the wall of the room. It was in centimeters.                                       
 
Weight measurement 
 Weight was measured for all subjects using a well calibrated scale. 
 
Waist circumference measurement 
 Waist circumference was measured by a manual metric scale in 
centimeters..                
 
Heart rate measurement 
 Radial pulse from the left hand for full minute, the subjects were at 
rest. 
 
Angiotensin II measurement 
 We used enzyme immunoassay (EIA) to measure the level of 
angiotensin II. 
 
Data analysis 
 We analyzed data using SPSS version 20. All data were included and 
represented as mean  and standard deviation. The relations between variables 
were computed using independent T test. Significance was considered at alpha 
<0.05. 
 
Results 
Comparison between the Means and Standard Deviations of Blood 
Pressure and other Variables in the Dead Sea and Sea Level Areas  
 We measure different variables to examine the impacts of altitudes on 
the health of persons. As it can be illustrated in table 1, participants in both 
groups had similar age groups (17.60 ±0.51 years), and no  significant 
variations were observed among participants between Dead Sea and sea level 
areas (P>0.05). 
 Table 1 also indicated that no significant differences in the means of 
weight, height, BMI, and waist circumferences were observed between Dead 
sea and sea level groups. The mean level of systolic blood pressure was 
122.42±10.53 mm Hg among subjects in the Dead Sea and this was 
significantly higher than the mean level of subjects in the area of Sea level 
(p=0.001). There was no statistically significant differences in the mean level  
of both groups for diastolic blood pressure. Participants from the Dead Sea 
had a significantly higher mean of mean blood pressure (91.64 ± 8.90 mm Hg) 
than those in the area of the Sea level (89.84 ± 8.72) (p=0.001).  
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Table 1:Comparison between the Means and Standard Deviations of Blood Pressure and 
other Variables in the Dead Sea and Sea Level Areas 
 Sea level Dead Sea  
P value Mean ± std Mean ± std Variables 
NS 17.60  ± 0.51 17.60 ±  0.51 Age 
NS  67.69  ±  8.70 67.31 ± 10.77 Weight/kg 
NS 170.50±  5.85 169.29 ± 6.52 Height/cm 
NS 23.26  ±  2.57 23.45 ± 3.27 BMI 
NS 76.38  ± 6.00 76.37 ± 10.26 Waist cir./c 
0.001* 118.07±11.64 122.42±10.53 SBP/mmHg 
NS 75.74  ± 8.48 76.31 ±   9.14 DBP/mmHg 
0.001* 89.84  ± 8.72 91.64 ±   8.90 MBP/mmHg 
NS 79.07  ± 6.46 79.74 ±   6.17 Pulse/minute 
NS 41.50  ± 3.27 42.17 ±   3.18 PCV 
NS: Not Significant 
 
The concentration of Angiotensin II Concentration in Dead Sea and Sea 
Areas 
 The mean level of Angiotensin II was 8.84± 4.65pg/ml among 
participants in the Dead Sea, while it was 11.21± 6.05 pg/ml. The difference 
in the concentration of angiotensin II between the study groups was not 
statistically significant (p>0.05) (table 2). 
Table 2: Comparison between Angiotensin II Concentration in Dead Sea and Sea Areas 
NS: Not Significant 
 
Discussion  
 Blood pressure is the main force for the hemodynamics that keeps 
continuous blood flow for all the body tissues which is essential for 
homeostasis. It is well known that blood pressure is regulated by two factors: 
first factor is the peripheral resistance which mainly depends on the elasticity 
of arterial system, mainly the arterioles, which determines the radius of these 
arteries and the influence of sympathetic activity through the baroreceptors 
during transient change of blood pressure. Also the level of the angiotensin 
hormone significantly can change the diameter of arterioles i.e. the peripheral 
resistance.  
 The second factor which regulates blood pressure is the blood volume 
which is mainly regulated by the level of rennin-angiotensin system that starts 
mainly from the kidney. So any condition that decreases or increases the level 
P value Mean ± SD 
(pg/ml) 
Target Area Mean ± SD 
(pg/ml) 
Target Area 
NS 11.21± 6.05 Sea level  8.84  ±  4.65 Dead Sea  
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of blood pressure will be antagonized by changing the level of angiotensin. 
The first line to change the radius is the vasoconstriction. It is the presence of 
oxygen that can cause vasoconstriction and hypoxia causes vasodilatation and 
this oxygen availability is different at different levels of altitude i.e. hypoxia 
at high altitude and high oxygen concentration at low altitude.            
 A study entitled by the effect of altitude on blood pressure in the Assir 
province of Saudi Arabia which has been carried out by the department of 
physiology, King Saud University has measured normal blood pressure, body 
weight, height, and packed cell volume (PCV) in healthy, normal Saudi adult 
males who were born and were living permanently at high altitude (3150 m) 
in southern Saudi Arabia (Habib et al., 1995). These values have been 
compared with those obtained from healthy, normal Saudi Arab adult males 
born and living permanently at low altitude (500 m above sea level). Results 
have showed that residents at high altitude have higher PCV than their lowland 
counterparts. Their mean body mass index (BMI) values have not been 
significantly different. Small but significant increase in systolic blood pressure 
(SBP) and diastolic blood pressure (DBP) have been observed in high-altitude 
residents (112 and 75 mm Hg, respectively) when compared with low altitude 
residents (109 and 71 mm Hg, respectively) (p < 0.001 for both SBP and DBP). 
 Another study which has been carried out by four universities in Italy 
in a shared work (Veglio et al., 1999) so as to evaluate the effects of exposure 
to a moderate altitude (2950 m) on heart rate (HR), blood pressure (BP) 
profile, and cardiovascular autonomic function, and their correlation with 
hemoglobin oxygen saturation (HbO2S), in untrained subjects with an age 
range between 6 and 83 years. In this study twenty-seven healthy 
normotensive subjects (age range 6–83 years; 8 children, 9 adults, and 10 
elderly subjects) underwent a battery of noninvasive cardiovascular reflex 
tests and 24-h ambulatory BP monitoring. Corrected QT interval was also 
calculated. HbO2S has been measured with a transcutaneous oxymeter. All 
measurements have been performed at about 200 m and repeated at 2950 m. 
24-h HR and systolic/diastolic BP mean values increased at 2950 m in children 
(% change respectively: 6.4±6.4, p<0.05; 6.5±4.0/13.5±6.9, p<0.05), adults 
(4.9±8.1, NS; 6.0±5.1/8.1±5.8, p<0.05), and elderly subjects (7.2±4.8, p<0.05; 
5.1±2.3/2.8±4.1, p<0.05 for systolic BP only). Standard deviation of BP mean 
values has increased during night-time in the adult group (p<0.05). All 
subjects have scored normal cardiovascular test results and no differences 
have been observed after exposure to 2950m, at both 1 hour and 24 hours from 
arrival. After exposure to high altitude, HbO2S has decreased significantly in 
the three groups, both on arrival and after 24 hours. No correlation has been 
found between changes in HbO2S and BP/HR responses, and cardiovascular 
test results. In conclusion, exposure to moderate altitudes, easily and often 
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reached by the general population, causes a small but significant increase in 
BP and HR in healthy untrained subjects of a wide age range (6–83 years).  
 It is worth mentioning that a clinical study which has been carried out 
in the Dead Sea area- Israel by Ben Gurion University (Paran, 
Neuman,Sukenik, 1998) has shown that seventy two elderly patients suffering 
from rheumatoid arthritis and osteoarthritis, both hypertensive and 
normotensive patients have demonstrated a decrease in BP during their stay in 
the Dead Sea area. This decrease has been most apparent on the 8th day of stay 
and has been moderated toward the 12th day of stay. 
 According to our knowledge this study is the only original 
physiological study to examine the effect of low altitude on blood pressure 
through which blood pressure, PCV, and angiotensin II were measured as part 
of a comprehensive study included sea level and high altitude level. 
 So, as to clarify the effect of altitude on blood pressure, angiotensin II 
has been measured. Other variables that affect blood pressure have been also 
measured so as to exclude their effect on it; these variables are BMI, waist 
circumference, pulse rate, gender and age. All these variables except pulse rate 
had no effect on the results of our study since our target subjects are healthy 
slim males and the same age , their values are insignificant( p value > 0.05). 
 Our results, however, are compatible with those of a study which has 
been performed in Abha, Saudi Arabia by the department of physiology in 
King Saud University in which they have tested the effect of altitude on blood 
pressure in the Assir province of Saudi Arabia (Habib et al., 1995) and it is 
also comparable with most of the international studies which have been carried 
out to clarify the effect of high altitude on blood pressure. The explanation of 
higher blood pressure in high altitude is that both the direct and indirect effects 
of the hypoxia are likely to contribute to causing the increase in sympathetic 
activity at high altitude. Hypoxia acts on vascular smooth muscle in the 
systemic circulation causing relaxation and therefore hypotension. This, in 
turn, will lead to baroreceptor-mediated sympathetic excitation. An additional 
mechanism for exciting sympathetic activity may also arise through 
stimulation of pulmonary arterial baroreceptors.  
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